Transplantation of mesenchymal stem cells (MSCs) for myocardial reconstruction has shown promise in both animal models and human phase 1 clinical studies.1,2 V
Background Islet transplantation represents an ideal therapeutic approach for treatment of type 1 diabetes but islet function and regeneration may be influenced